Ignite Creation Date:
2025-12-24 @ 7:22 PM
Ignite Modification Date:
2025-12-29 @ 11:46 PM
Study NCT ID:
NCT01222403
Status:
COMPLETED
Last Update Posted:
2019-06-12
First Post:
2010-10-12
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Post-marketing Study to Monitor the Safety of a MF59-adjuvanted Influenza Vaccine Administered in Korean Subjects Aged 65 Years or Older
Sponsor:
Novartis Vaccines
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-10
Start Date Type:
None
Primary Completion Date:
2014-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-10
Completion Date Type:
ACTUAL
First Submit Date:
2010-10-12
First Submit QC Date:
None
Study First Post Date:
2010-10-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-09-09
Results First Submit QC Date:
None
Results First Post Date:
2015-10-12
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-05-31
Last Update Post Date:
2019-06-12
Last Update Post Date Type:
ACTUAL